Cargando…

Biomarkers in the management of acute heart failure: state of the art and role in COVID‐19 era

Acute heart failure (AHF) affects millions of people worldwide, and it is a potentially life‐threatening condition for which the cardiologist is more often brought into play. It is crucial to rapidly identify, among patients presenting with dyspnoea, those with AHF and to accurately stratify their r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aleksova, Aneta, Sinagra, Gianfranco, Beltrami, Antonio P., Pierri, Alessandro, Ferro, Federico, Janjusevic, Milijana, Gagno, Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652929/ https://www.ncbi.nlm.nih.gov/pubmed/34609075 http://dx.doi.org/10.1002/ehf2.13595

Ejemplares similares

The Role of Exercise-Induced Molecular Processes and Vitamin D in Improving Cardiorespiratory Fitness and Cardiac Rehabilitation in Patients With Heart Failure
por: Aleksova, Aneta, et al.
Publicado: (2022)

Traditional and Emerging Biomarkers in Asymptomatic Left Ventricular Dysfunction—Promising Non-Coding RNAs and Exosomes as Biomarkers in Early Phases of Cardiac Damage
por: Janjusevic, Milijana, et al.
Publicado: (2021)

From Brain to Heart: Possible Role of Amyloid-β in Ischemic Heart Disease and Ischemia-Reperfusion Injury
por: Gagno, Giulia, et al.
Publicado: (2020)

Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis
por: Janjusevic, Milijana, et al.
Publicado: (2022)

Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review
por: Aleksova, Aneta, et al.
Publicado: (2021)

Common Shared Pathogenic Aspects of Small Vessels in Heart and Brain Disease
por: Moretti, Rita, et al.
Publicado: (2022)

Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality
por: Aleksova, Aneta, et al.
Publicado: (2022)

Pulmonary Embolism Presenting with Pulmonary Infarction: Update and Practical Review of Literature Data
por: Gagno, Giulia, et al.
Publicado: (2022)

What the Cardiologist Needs to Consider in the Management of Oncologic Patients with STEMI-Like Syndrome: A Case Report and Literature Review
por: Aleksova, Aneta, et al.
Publicado: (2021)

Diabetes Mellitus and Vitamin D Deficiency: Comparable Effect on Survival and a Deadly Association after a Myocardial Infarction
por: Aleksova, Aneta, et al.
Publicado: (2020)

Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone
por: Aleksova, Aneta, et al.
Publicado: (2019)

COVID-19-Related Myocarditis: Are We There Yet? A Case Report of COVID-19-Related Fulminant Myocarditis
por: Pierri, Alessandro, et al.
Publicado: (2023)

Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction
por: Gagno, Giulia, et al.
Publicado: (2019)

Preserved Skeletal Muscle Mitochondrial Function, Redox State, Inflammation and Mass in Obese Mice with Chronic Heart Failure
por: Gortan Cappellari, Gianluca, et al.
Publicado: (2020)

n-3 PUFA-Enriched Diet Preserves Skeletal Muscle Mitochondrial Function and Redox State and Prevents Muscle Mass Loss in Mice with Chronic Heart Failure
por: Gortan Cappellari, Gianluca, et al.
Publicado: (2023)

Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy
por: Aleksova, Aneta, et al.
Publicado: (2017)

Cardiology of the future: xenotransplantation with porcine heart
por: Sinagra, Gianfranco, et al.
Publicado: (2022)

Multi-state modelling of heart failure care path: A population-based investigation from Italy
por: Gasperoni, Francesca, et al.
Publicado: (2017)

Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction
por: Aleksova, Aneta, et al.
Publicado: (2019)

Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome
por: Barazzoni, Rocco, et al.
Publicado: (2013)

Differential Role of Circulating microRNAs to Track Progression and Pre-Symptomatic Stage of Chronic Heart Failure: A Pilot Study
por: D’Alessandra, Yuri, et al.
Publicado: (2020)

Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction
por: Stolfo, Davide, et al.
Publicado: (2022)

Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction
por: Stolfo, Davide, et al.
Publicado: (2023)

State-of-the-art Structural Interventions in Heart Failure
por: Park, Jeffrey, et al.
Publicado: (2019)

Frailty and heart failure: State‐of‐the‐art review
por: Talha, Khawaja M., et al.
Publicado: (2023)

Heart failure with mid-range or mildly reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2021)

Letter regarding the article “Hypocapnia is an independent predictor of in‐hospital mortality in acute heart failure”
por: Guarnaccia, Alberto, et al.
Publicado: (2023)

Using Vertebrate Stem and Progenitor Cells for Cellular Agriculture, State-of-the-Art, Challenges, and Future Perspectives
por: Knežić, Teodora, et al.
Publicado: (2022)

Current state-of-the-art of device therapy for advanced heart failure
por: Lee, Lawrence S., et al.
Publicado: (2014)

Heart Failure with Mid-Range Ejection Fraction - State of the Art
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2019)

Chronic Heart Failure in Children: State of the Art and New Perspectives
por: Castaldi, Biagio, et al.
Publicado: (2023)

Sex differences in natural history of cardiovascular magnetic resonance‐ and biopsy‐proven lymphocytic myocarditis
por: Castrichini, Matteo, et al.
Publicado: (2022)

Autophagy and Inflammasome Activation in Dilated Cardiomyopathy
por: Caragnano, Angela, et al.
Publicado: (2019)

Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature
por: Palazzuoli, Alberto, et al.
Publicado: (2023)

A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies
por: Serelli-Lee, Victoria, et al.
Publicado: (2022)

Extracellular Vesicles: How Drug and Pathology Interfere With Their Biogenesis and Function
por: Cesselli, Daniela, et al.
Publicado: (2018)

Effect of prehospital treatment in STEMI patients undergoing primary PCI
por: Fabris, Enrico, et al.
Publicado: (2022)

Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure
por: Rayol, Sérgio Costa, et al.
Publicado: (2019)

Cardiac Cell Senescence and Redox Signaling
por: Cesselli, Daniela, et al.
Publicado: (2017)

Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art
por: Marchioni, Michele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gc3l916m84kaib4drg8p81huuv